Aurobindo Pharma consolidated net profit rises 7.95% in the September 2024 quarter
Sales rise 6.93% to Rs 7646.21 crore
Net profit of Aurobindo Pharma rose 7.95% to Rs 817.38 crore in the quarter ended September 2024 as against Rs 757.18 crore during the previous quarter ended September 2023. Sales rose 6.93% to Rs 7646.21 crore in the quarter ended September 2024 as against Rs 7150.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales7646.217150.71 7 OPM %20.4819.21 -PBDT1589.741493.14 6 PBT1207.461075.64 12 NP817.38757.18 8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 11 2024 | 7:30 AM IST